Latest Non-Hodgkin lymphoma Stories
Cancer Monthly, the only centralized source of cancer treatment results, adds two new cancers to the database. Raleigh, NC (PRWEB) March 08, 2012 Cancer
Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method yet for imaging a form of Non-Hodgkin’s disease called mantle cell lymphoma, a relatively rare and devastating blood cancer.
WHITE PLAINS, N.Y., Aug.
SILVER SPRING, Md., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).
- A hairdresser.